Edesa Biotech, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.58 | -$0.58 | -$0.58 |
Q2 2024 | 2 | -$0.63 | -$0.45 | -$0.54 |
Edesa Biotech, Inc. Earnings Date And Information
Edesa Biotech, Inc. last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.52 earnings per share for the quarter, topping analysts' consensus estimates of $-0.58 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Edesa Biotech, Inc. has generated $-3 earnings per share over the last year ($-2.93 diluted earnings per share) and currently has a price-to-earnings ratio of -2.1. Edesa Biotech, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 13th, 2024 based on prior year's report dates.
Edesa Biotech, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/09/2024 | Q3 2024 | -$0.58 | -$0.52 | 0.06 | $0 | $0 |
05/10/2024 | Q2 2024 | -$0.69 | -$0.58 | 0.11 | $0 | |
02/09/2024 | Q1 2024 | -$1.21 | -$0.54 | 0.67 | $0 | |
12/15/2023 | Q4 2023 | -$0.71 | -$0.57 | 0.14 | $-1,118,100 | |
08/09/2023 | Q3 2023 | -$1.19 | -$0.68 | 0.51 | $0 | |
05/11/2023 | Q2 2023 | -$1.19 | -$0.82 | 0.37 | $0 | |
02/10/2023 | Q1 2023 | -$1.33 | -$0.87 | 0.46 | $1.12 M | |
03/27/2023 | Q4 2022 | -$1.22 | $0 | |||
08/12/2022 | Q3 2022 | -$2.52 | -$2.61 | -0.09 | $0 | |
05/13/2022 | Q2 2022 | -$2.59 | -$2.31 | 0.28 | $0 | |
02/14/2022 | Q1 2022 | -$2.80 | -$2.30 | 0.5 | $0 | |
12/28/2021 | Q4 2021 | -$2.59 | -$1.95 | 0.64 | $-3,511,315 | |
08/13/2021 | Q3 2021 | -$2.24 | -$2.51 | -0.27 | $0 | |
05/14/2021 | Q2 2021 | -$2.10 | -$1.36 | 0.74 | $0 | |
02/16/2021 | Q1 2021 | -$1.33 | -$1.80 | -0.47 | $0 | |
12/07/2020 | Q4 2020 | -$1.47 | -$1.51 | -0.04 | $50,000 | $500 |
08/12/2020 | Q3 2020 | -$1.47 | -$1.40 | 0.07 | $50,000 | $109,985 |
05/15/2020 | Q2 2020 | -$1.82 | -$1.19 | 0.63 | $110,516 | |
02/13/2020 | Q1 2020 | -$1.02 | $107,800 | |||
09/30/2019 | Q4 2019 | -$0.88 | $114,600 | $410,370 |
Edesa Biotech, Inc. Earnings: Frequently Asked Questions
-
When is Edesa Biotech, Inc.'s earnings date?
Edesa Biotech, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 13th, 2024 based off last year's report dates.
-
Did Edesa Biotech, Inc. beat their earnings estimates last quarter?
In the previous quarter, Edesa Biotech, Inc. (:EDSA) reported $-0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.58 by $0.06.
-
How can I listen to Edesa Biotech, Inc.'s earnings conference call?
The conference call for Edesa Biotech, Inc.'s latest earnings report can be listened to online.
-
How can I read Edesa Biotech, Inc.'s conference call transcript?
The conference call transcript for Edesa Biotech, Inc.'s latest earnings report can be read online.
-
How much profit does Edesa Biotech, Inc. generate each year?
Edesa Biotech, Inc. (:EDSA) has a recorded net income of $0. Edesa Biotech, Inc. has generated $-2.93 earnings per share over the last four quarters.
-
What is Edesa Biotech, Inc.'s price-to-earnings ratio?
Edesa Biotech, Inc. (:EDSA) has a price-to-earnings ratio of -2.1 and price/earnings-to-growth ratio is -0.03.